{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/58400"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/58400","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang.","abstract":"The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more \"venture-oriented\" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners.","abstract_html":"The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more "venture-oriented" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners.","abstract_has_math":false,"creators":["Chang, Joanne"],"institution":"Massachusetts Institute of Technology","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Harvard University--MIT Division of Health Sciences and Technology.","school":null,"contributors":[],"advisors":["Fiona E. Murray and Chris Varma."],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010","date_published":"2010","updated_at":"2026-07-22T22:22:25Z","subjects":["Harvard University--MIT Division of Health Sciences and Technology."],"languages":["eng"],"rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"rights_urls":["http://dspace.mit.edu/handle/1721.1/7582"],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1721.1/58400","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Fiona E. Murray and Chris Varma."]},{"key":"dc:contributor.department","label":"Department","values":["Harvard University--MIT Division of Health Sciences and Technology."]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Harvard University--MIT Division of Health Sciences and Technology."]},{"key":"dc:creator","label":"Author","values":["Chang, Joanne"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2010-09-03T18:36:02Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2010-09-03T18:36:02Z"]},{"key":"dc:date.issued","label":"Date","values":["2010"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Harvard University--MIT Division of Health Sciences and Technology."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://dspace.mit.edu/handle/1721.1/7582"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1721.1/58400"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010.","Cataloged from PDF version of thesis.","Includes bibliographical references (p. 69-71)."]},{"key":"dc:description.abstract","label":"Abstract","values":["The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more \"venture-oriented\" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["S.M."]},{"key":"dc:title","label":"Title","values":["Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang."]}]}],"canonical_facts":{"dc:contributor.advisor":["Fiona E. Murray and Chris Varma."],"dc:contributor.department":["Harvard University--MIT Division of Health Sciences and Technology."],"dc:contributor.other":["Harvard University--MIT Division of Health Sciences and Technology."],"dc:creator":["Chang, Joanne"],"dc:date.accessioned":["2010-09-03T18:36:02Z"],"dc:date.available":["2010-09-03T18:36:02Z"],"dc:date.issued":["2010"],"dc:description":["Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010.","Cataloged from PDF version of thesis.","Includes bibliographical references (p. 69-71)."],"dc:description.abstract":["The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more \"venture-oriented\" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners."],"dc:description.degree":["S.M."],"dc:identifier.uri":["http://hdl.handle.net/1721.1/58400"],"dc:language.iso":["eng"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission."],"dc:rights.uri":["http://dspace.mit.edu/handle/1721.1/7582"],"dc:subject":["Harvard University--MIT Division of Health Sciences and Technology."],"dc:title":["Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang."],"dc:type":["Thesis"]},"updated_at":"2026-07-22T22:22:25Z"}